I got the letter and there are so many inaccuracies that I could drive a bus through it.
I'll start with the very first sentence. Ilumen is not a diagnostic aid and the author of the letter of all people, should know that.
Also I would remind the author that she was very much a part of the executive team during the period of the "dramatic cash burn rate" and the dramatic decline in share price. Why in the name of God would we vote her or anyone associated with her back in?
In addition debt funding for predominently a pre-revenue medical research company is never a good idea and the author should know that too if she has aspirations of being a board member.
Someone should tell the incoming CEO of the supposed disarray. He obviously does not see it.
Regarding the departure of the previous chief executive, 6 people (Board members - regardless of who they are) were unanimous in the action that was taken.
